CompletedPhase 1NCT03879603

VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults

Studying Eastern equine encephalitis

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator: Julie E Ledgerwood, DO
VRC/NIAID/NIH
Intervention: VRC-WEVVLP073-00-VP(biological)
Enrollment: 30 enrolled
Eligibility: 18-50 years · All sexes
Timeline: 2019 – 2020

Study locations (1)

The Hope Clinic of the Emory Vaccine Center, Decatur, Georgia, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03879603 on ClinicalTrials.gov

← Back to all trials